Acute Variceal Bleeding in Patients with Liver Cirrhosis with and without Diabetes
Journal Title: Liver Research – Open Journal - Year 2015, Vol 1, Issue 1
Abstract
Objectives: To study the effect of diabetes mellitus on presentations, course, and outcome of acute variceal bleeding in cirrhotic patients. Methods: We compared 2 matched groups of patients, a diabetic group and non-diabetic group, where all of the patients presented with acute esophageal varices due to liver cirrhosis. All patients underwent history taking, clinical examination, emergency treatment, upper endoscopy, laboratory investigations and abdominal ultrasound; they followed up until hospital discharge. Results: The diabetic group showed statistically significant unstable course in 73.3% of them compared to 36.6% in the control; more attacks of melena (2.2±1.03) compared to control (1.7±0.88), and also had significantly disturbed level of consciousness compared to control (36.7% versus 10% respectively); moreover they have significantly more right and left lobe enlargement than control (70% versus 26.7%, and 66.7 versus 40% respectively), significantly more echogenic liver (70% versus 33.3), highly significant more portal vein dilatations (73.3% versus 16.7%) and highly significant more collaterals (50% versus 23.3%); the splenic size was also significantly more enlarged in diabetics (60%) than control (40%), and the splenic vein diameter was significantly more dilated in diabetics (33.3%) versus control group (6.7%); finally the mortality was more in the diabetic group. Conclusions: Diabetic patients with acute variceal bleeding may show more morbidity and mortality rates.
Authors and Affiliations
Mohammad Mosaad
Iron and Copper Toxicity in Rat Liver: A Kinetic and Holistic Overview
Iron (Fe) and copper (Cu) overloads in rats showed a dose and time dependent metal accumulation in liver with its associated toxicity. The increased contents of the transition metals markedly enhanced the endogenous free...
Non-Alcoholic Fatty Liver Disease: The Effect of Bile Acids and Farnesoid X Receptor Agonists on Pathophysiology and Treatment
Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic in light of its two predisposing factors, a surge in both obesity and diabetes rates with reports of between 70-80% of obese individuals in Western countr...
Acute Variceal Bleeding in Patients with Liver Cirrhosis with and without Diabetes
Objectives: To study the effect of diabetes mellitus on presentations, course, and outcome of acute variceal bleeding in cirrhotic patients. Methods: We compared 2 matched groups of patients, a diabetic group and non-dia...
The Prescribers’ Dilemma: Treatment of Hepatitis C Infection for Medicaid Insured Patients in United States
Introduction of Direct Acting Antivirals (DAA) to Hepatitis C Virus (HCV) treatment armamentarium has offered a great boost to the providers’ confidence to safely and effectively treat HCV infection in the majority of pa...
Cardiovascular Disease and NASH
Non-alcoholic fatty liver disease (NAFLD) and Non-alcoholic steatohepatitis (NASH) are associated with cardiovascular events and Metabolic Syndrome (MetS). NAFLD is considered to be a hepatic manifestation of MetS and ha...